Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01858 CHUNLI MEDICAL
RT Nominal up8.470 +0.190 (+2.295%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others463,069-0.071%463,396392,949162,791156,026
Land & other Lease Assets118,477-2.058%120,967123,571102,348102,488
Intangible Assets33,21974.143%19,07610,2011,204671
Interests in Asso. & JCEs0--0000
Other Non-current Assets29,4368.068%27,23825,17223,50914,732

644,2012.144%630,678551,893289,854273,917
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories434,48667.245%259,789159,677168,614191,375
Trade Receivables441,721-42.438%767,386527,789371,076252,767
Cash & Bank Balances1,266,36832.300%957,1941,736,494690,116464,177
Other Current Assets862,7868.565%794,72023,80422,18727,077
Assets Held for Sale0--0000

3,005,3608.142%2,779,0892,447,7641,251,994935,397
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables225,500-5.167%237,787142,41690,29286,404
S-T Debt & Leases1,22177.453%6881,22611,4560
Other Current Liabilities449,95125.920%357,330295,977267,098224,649
Liab asso w/ Assets Held for Sale0--0000

676,67313.573%595,805439,619368,845311,053
Net Current Assets2,328,6876.660%2,183,2842,008,145883,148624,344
Total Assets Less Current Liabilities2,972,8885.648%2,813,9622,560,0381,173,002898,261
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases532-15.070%62606680
Other Non-current Liabilities93,121-0.550%93,63790,96192,74691,671

93,653-0.647%94,26290,96193,41491,671
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital383,569-0.185%384,280384,280345,852138,341
  Reserves2,493,8986.786%2,335,4202,084,797733,736668,250
  Others0--0000
Shareholders' Funds2,877,4675.801%2,719,7002,469,0771,079,588806,591
Non-controlling Interests1,769--0000
Others0--0000

2,879,2355.866%2,719,7002,469,0771,079,588806,591
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments0--0000
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 27/12/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 79,026,079
%Change-37.319%
EPS / (LPS)RMB 0.210
NBV Per Share (¥)RMB 7.346
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.